Folliculotropic mycosis fungoides responding to bexarotene gel

Journal of Drugs in Dermatology

Volumn 7, Issue 2, 2008, Pages 169-171

  Walling, Hobart W ^a   Swick, Brian L ^b   Gerami, Pedram ^c   Scupham, Richard K ^d  

^a Town Square Dermatology ^*  (United States)

^b UNIVERSITY OF IOWA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Iowa Pathology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEXAROTENE; TETRALIN DERIVATIVE;

AGED; ARTICLE; CASE REPORT; GEL; HUMAN; MALE; MYCOSIS FUNGOIDES; PATHOLOGY; TREATMENT OUTCOME;

AGED; ANTICARCINOGENIC AGENTS; GELS; HUMANS; MALE; MYCOSIS FUNGOIDES; TETRAHYDRONAPHTHALENES; TREATMENT OUTCOME;

EID: 44449166728     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Girardi M, Heald PW, Wilson LD. The pathogenesis of mycosis fungoides. N Engl J Med. 2004;350:1978-1988. (Pubitemid 38580201)
2. Hunzeker CM, Fangman W, Latkowski JA. Folliculotropic mycosis fungoides. Dermatol Online J. 2007;13:5.
3. Hodak E, Feinmesser M, Segal T, et al. Follicular cutaneous T-cell lymphoma: a clinicopathological study study of nine cases. Br J Dermatol. 1999;141:315-322. (Pubitemid 29398004)
4. Gerami P, Guitart J. The spectrum of histopathologic and immunohistochemical findings in folliculotropic mycosis fungoides. Am J Surg Pathol. 2007;31:1430-1438. (Pubitemid 47329681)
5. Monopoli A, Annessi G, Lombardo GA, et al. Purely follicular mycosis fungoides without mucinosis: report of two cases with review of the literature. J Am Acad Dermatol. 2003;48:448-452. (Pubitemid 36337086)
6. Nashan D, Faulhaber D, Ständer S, et al. Mycosis fungoides: a dermatological masquerader. Br J Dermatol. 2007;156:1-10. (Pubitemid 44924138)
7. van Doorn, Scheffer E, Willemze R. Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. Arch Dermatol. 2002;138:191-198. (Pubitemid 34160393)
8. Gerami P, Rosen S, Kuzel T, et al. Folliculotropic mycosis fungoides: An aggressive variant of CTCL. Arch Dermatol. In press.
9. Freiman A, Sasseville D. Treatment of mycosis fungoides: overview. J Cutan Med Surg. 2006;10:228-233. (Pubitemid 351506635)
10. Huber MA, Staib G, Pehamberger H, Scharffetter-Kochanek K.Management of refractory early-stage cutaneous T-cell lymphoma. Am J Clin Dermatol. 2006;7:155-169. (Pubitemid 43845340)
11. Querfeld C, Nagelli LV, Rosen ST, et al. Bexarotene in the treatment of cutaneous T-cell lymphoma. Expert Opin Pharmacother. 2006;7:907-915.
12. Lain T, Talpur R, Duvic M. Long-term control of mycosis fungoides of the hands with topical bexarotene. Int J Dermatol. 2003;42:238-241. (Pubitemid 41709837)
13. McGinnis KS, Junkins-Hopkins JM, Crawford G, et al. Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms. J Am Acad Dermatol. 2004;50:375-379. (Pubitemid 38316130)
14. Zhang C, Duvic M. Treatment of cutaneous T-cell lymphoma with retinoids. Dermatol Ther. 2006;19:264-271. (Pubitemid 44470110)
15. Breneman D, Duvic M, Kuzel T, et al. Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma. Arch Dermatol. 2002;138:325-332. (Pubitemid 34226330)
16. Heald P, Mehlmauer M, Martin AG, et al, and the Worldwide Bexarotene Study Group. Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial. J Am Acad Dermatol. 2003;49:801-815. (Pubitemid 37314867)
17. Mitteldorf C, Stadler R, Bertsch HP, Neumann C. Folliculotropic mycosis fungoides with CD30+ large-cell transformation in a young woman: beneficial effect of bexarotene. Br J Dermatol. 2007; 156:584-586.
18. Shistik G, Scalf LA, Fenske N, Glass LF. Follicular mycosis fungoides: successful treatment with oral bexarotene. J Drugs Dermatol. 2004;3:301-304.
19. Roeschm A, Schleyer V, Landthaler M, Vogt T. Follicular mycosis fungoides: variability of a rare entity. Skinmed. 2005;4:12-17.
20. Apisarnthanarax N, Ha CS, Duvic M. Mycosis fungoides with follicular mucinosis displaying aggressive tumor-stage transformation: successful treatment using radiation therapy plus oral bexarotene combination therapy. Am J Clin Dermatol. 2003;4:429-433. (Pubitemid 36724130)